RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$1.32
-0.07 (-5.06%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,401.5% upside
Low Target
$14.35
Average Target
$19.82
High Target
$27.60
Current Price
$1.32
Current
$1.32
$1.32
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Scenario Analysis
Bear Case
$14.35
987.1%
Low target
Base Case
$19.82
+1,401.5%
Avg target
Bull Case
$27.60
+1,990.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$12.60
-89.5% from high
52-Week Low
$1.33
+-0.8% from low
Target vs 52W High
$19.82
+57.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |